BDO Wealth Advisors’s Array Biopharma Inc ARRY Stock Holding History

BDO Wealth Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-160	Closed	-$7K	–	672
2019 Q2	$7K	Sell	160 -50	-24%	-$1.4K	﹤0.01%	477
2019 Q1	$5K	Buy	210 +110	+110%	+$2.29K	﹤0.01%	482
2018 Q4	$1K	Hold	100	–	–	﹤0.01%	538
2018 Q3	$2K	Hold	100	–	–	﹤0.01%	587
2018 Q2	$2K	Sell	100 -100	-50%	-$1.59K	﹤0.01%	607
2018 Q1	$3K	Hold	200	–	–	﹤0.01%	495
2017 Q4	$3K	Buy	+200	New	+$2.27K	﹤0.01%	415

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

BDO Wealth Advisors's ARRY Position: Q3 2019 in Review

BDO Wealth Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 160 shares — an estimated $7K sold.

BDO Wealth Advisors first reported a position in ARRY in Q4 2017 and held it in 7 quarters. The position peaked at $7K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

BDO Wealth Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
BDO Wealth Advisors sold 160 Array Biopharma Inc shares in Q3 2019, an estimated $7K.
BDO Wealth Advisors first reported a position in Array Biopharma Inc in Q4 2017 and held it in 7 quarters.
BDO Wealth Advisors's Array Biopharma Inc position peaked at $7K in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on BDO Wealth Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.